Inhibitors of the Enzyme Purine Nucleoside Phosphorylase as Potential Therapy for Psoriasis

By  

Current Pharmaceutical Design, Vol. 6, Iss. 9, 2000-06 ,pp. : 943-959

Bentham Science Publishers

Access to resources Recommend Favorite

Transition States and Inhibitors of the Purine Nucleoside Phosphorylase Family

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 13, 2005-10 ,pp. : 1237-1258

Bentham Science Publishers

Access to resources Recommend Favorite

Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors

By  

Current Pharmaceutical Design, Vol. 23, Iss. 45, 2018-02 ,pp. : 7003-7024

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 413-422

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Methods for De novo Protein Design and its Applications to the Human Immunodeficiency Virus 1, Purine Nucleoside Phosphorylase, Ubiquitin Specific Protease 7, and Histone Demethylases

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 264-278

Bentham Science Publishers

Access to resources Recommend Favorite